












Abstract: Based on the options provided by the 
international drug control legal framework, this 
paper considers the rehabilitative measures of 
treating, educating or reintegrating drug users as 
alternatives or additions to conviction or 
punishment that are established in the laws of 
many countries in Europe today. Distinguishing 
them from ‘alternatives to prison’, it outlines the 
variety of rehabilitative measures in use and sets 
out the main issues in their design, 
implementation and evaluation.
The paper finds that alternatives to punishment 
are available across Europe to varying degrees 
and with inconclusive evaluations suggesting 
positive results. The success of these measures 
depends partly on the degree to which they are 
accurately targeted to specific objectives and 
specific users. The policy arguments in favour of 
them seem to have developed along two lines: 
reducing harms to the individual and society by 
problem drug users, and addressing structural 
burdens on the justice system by non-problem 
users. Yet the paper finds that this distinction, or 
prioritisation, is not always clear in the design or 
implementation of the different measures, which 
can in turn affect the few evaluations carried out. 
Compromises between the two different aims of 
the laws (to treat or to punish these offenders) 
can also have unintended effects on the 
outcomes. Clarity on these issues should assist 
development and implementation of more 
successful measures in the future.
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I Introduction
In recent years, Europe’s policymakers have come under 
increasing pressure to find effective and appropriate 
responses to manage people who come into contact with the 
criminal justice system for drug law offences. The numbers 
reflect the importance of this challenge, with over one million 
use-related drug law offences reported in European countries 
in 2013 (EMCDDA, 2015). In this context, the debate on 
providing alternatives to punishment and prison has returned 
to the top of the policy agenda. The EU Drugs Strategy 
(2013–20) states that ‘In order to prevent crime, avoid 
recidivism and enhance the efficiency and effectiveness of the 
criminal justice system while ensuring proportionality, the EU 
shall encourage, where appropriate, the use, monitoring and 
effective implementation of drug policies and programmes 
including arrest referral and appropriate alternatives to 
coercive sanctions (such as education, treatment, 
rehabilitation, aftercare and social reintegration) for drug-
using offenders’ (Council of the European Union, 2012). It is 
thus an area that warrants further investigation, and where 
there has been a significant accumulation of new and diverse 
experience and evidence at the national level. This paper takes 
a first step at both defining the concepts involved, and in 
setting out the broad range of measures utilised. 
The use and supply of illicit drugs is a global issue, which is 
governed by an international drug control system that has 
developed over many years. This includes a range of 
international conventions, to which most countries are 
signatories. These seek to restrict access to psychoactive 
substances that are considered likely to be misused and result 
in significant harms to users and society, while still permitting 
their use for medical and scientific purposes. This 
international legal framework asks for unauthorised drug 
possession to be penalised, according to the seriousness of 
the offence, with prison or other criminal penalties (United 
Nations, 1961, 1971, 1988). This was originally intended to 
deter or punish those involved in the supply chain, but in 
recent decades has been visibly and vigorously applied to 
deter and punish drug users also. Yet that same international 
framework has for 40 years also made it clear that users of 
drugs may be given, ‘as an alternative to conviction or 
punishment or in addition’, measures such as ‘treatment, 
education, aftercare, rehabilitation and social reintegration’, 
i.e. rehabilitative rather than deterrent or retributive responses 
(United Nations, 1961, as amended, Article 36(1)(b)). These 
alternatives have received more attention in the last 20 years 
as the evidence builds to question the effectiveness of the 
deterrence model, and users, particularly problem drug users, 
are viewed more as sick than as deviant. 
These alternatives or additions to punishment or coercive 
sanctions may be implemented to solve a variety of problems 
at different levels. The first is at the level of the individual — to 
deliver a proportionate response to an offence, to treat 
addiction and reduce the stigma attached to it. The second is 
at the level of society — to reduce drug-related crime such as 
acquisitive crime, as treatment has been shown to be effective 
at reducing such crime (Holloway et al., 2008), or to reduce 
disease transmission and other public health and societal 
harms. And the third is at the level of state structure — to 
reduce the pressure on the criminal justice system and the 
resources used by courts and prisons. The objectives of the 
policy can therefore be manifold. 
The targets of the policy — the drug users — may also have 
varied profiles but, for ease of reading, this report will consider 
there to be two broad groups of users. The first group is 
problem or high-risk drug users. The EMCDDA defines 
high-risk drug use as ‘recurrent drug use that is causing actual 
harms (negative consequences) to the person (including 
dependence, but also other health, psychological or social 
problems) or is placing the person at a high probability/risk of 
suffering such harms’ (EMCDDA, 2013). Across Europe 
generally, problem drug users represent a small share of the 
total number of drug users, but their use patterns and 
behaviours are the cause of significant social harms, such as 
drug-related crime and disease. The main problems are at the 
individual and societal level and the involvement of this group 
of users with the criminal justice system may often be a result 
of acquisitive offending and disorder, rather than drug 
offences. By contrast, while there are far more of the second 
group, i.e. non-problem drug users, their patterns of use are 
generally associated with lower levels of harm. Large numbers 
of drug law offenders are registered for cannabis offences and 
may make up the majority of drug users entering the justice 
system; in some countries, these numbers cause problems at 
the structural level. 
Interest has grown in the use of alternatives or additions to 
punishment for drug users, as concerns about the cost-
effectiveness of more punitive approaches have increased. In 
the current context of financial austerity, reducing levels of 
criminal justice expenditure and achieving value for money will 
be increasingly important. However, although there have been 
a number of high-profile descriptions of certain alternative 
approaches for dealing with drug-using offenders — for 
example drug courts and the Portuguese model — a more 
general overview of the wide variety of alternatives that have 
been used within Europe has been lacking. This report aims to 
provide such an overview — of the alternatives, their target 
groups, and what is known about their effectiveness — to 
assist those policymakers considering such approaches to 
choose a more appropriate response to their specific issue. It 
may also assist those practitioners in the justice and health 
fields who are involved in designing, implementing and 
evaluating these systems in the different countries, and help 
to clarify their role and the roles of their counterparts in these 
multidisciplinary measures. This paper primarily draws on the 
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I Context and definitions
I History and shifting focus
A summary of historical developments in the concept of 
alternatives to punishment in drug control policy can 
contextualise some of the current issues in this area. 
Early international conventions focused more on controlling 
the trade in drugs than on the drug users. For example, the 
International Opium Convention of 1912 established a system 
of international control of trade, with punishments for non-
compliance, and countries were simply asked to ‘examine the 
possibility of enacting laws or regulations making it a penal 
offence to be in illegal possession’ of opium products 
(Article 20). 
The first significant convention to show concern for protecting 
or improving the health of drug users was the United Nations 
Single Convention on Narcotic Drugs of 1961, which 
established the modern international legal framework for drug 
control. It opens with the Parties declaring themselves to be 
‘Concerned with the health and welfare of mankind’, and 
Article 38 clearly instructed Parties to ‘give special attention 
to the provision of facilities for the medical treatment, care 
and rehabilitation of drug addicts’. Nevertheless, Article 36 (1), 
much as its predecessors did, requested that drug possession 
and distribution be a punishable offence, with serious 
offences liable to adequate punishment such as 
main EMCDDA data collections in this area carried out since 
2006 (see the box on methods), but does not constitute an 
exhaustive review of the literature. 
The report begins with a brief review of the history of the topic 
and clarifies the definition of ‘alternatives to punishment’ 
discretely from the common term ‘alternatives to prison’. It 
then illustrates some of the various legal mechanisms 
associated with the range of approaches used in Europe 
today, with a brief comment on drug courts in the United 
States, and discusses the extent of their use, where known. 
Next, the report looks at whether these measures might be 
considered successful or not. Finally, the report provides a 
framework for considering the various different measures and 
the type of drug users at whom each measure should be 
aimed, with guidance to assist more robust evaluations in the 
future. The report does not go into details of the design of 
successful treatment programmes, information on which can 
be found online in the EMCDDA Best practice portal. The term 
‘alternatives to punishment’ is used throughout the report as 
shorthand to describe the wide range of measures with a 
rehabilitative or preventative focus that are used instead of or 
alongside more traditional criminal justice measures for 
drug-using offenders. The extent to which they replace such 
measures, or are simply additional to them, will vary from 
place to place and over time, and is often difficult to identify in 
practice.
This paper is based on reports made to the EMCDDA by the 
Reitox network of national focal points and information 
submitted by the legal correspondents network, 
supplemented by other information where available. 
Sources include: 
n  annual Reitox reports, with a particular focus on those 
for 2009–11; 
n  the special chapter of those reports on sentencing 
statistics in 2008; 
n  structured questionnaires on ‘alternatives to prison’ 
completed by national focal points in 2006 and 2010; 
and 
n  the ELDD Topic overview on ‘treatment alternatives to 
prison’. 
The study also draws on other sources, such as the 
European Commission’s research project on quasi-
compulsory treatment (2002–05), and from the Council of 
Europe Pompidou Group’s Criminal Justice Forum, which 
focused on quasi-coerced treatment (2007–10), as well as 
other published sources. The measures discussed in these 
sources may include treatment alongside punishment and 
alternatives to prison, reflecting the unclear ‘boundaries’ of 
the topic.
While this study has the advantage of drawing on 
information that may not be readily available in the 
academic literature, particularly concerning the types of 
interventions available, it is not a systematic review, and 
may have gaps. It is also important to note that a particular 
challenge in this area is that the increasing interest in the 
potential of such alternatives to punishment means the 
situation in many countries is changing quite rapidly, so 
some of the information reported may no longer be 
accurate.
Methods
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terms appear to have been used interchangeably in important 
policy documents. The 1998 UN Declaration on the Guiding 
Principles of Drug Demand Reduction reminded countries to 
consider alternatives to punishment (United Nations, 1998b). 
In 2004, when discussing how to respond to drug users 
coerced into trafficking, the INCB supported treatment as an 
alternative ‘to prison’ (United Nations, 2005, para. 27), 
highlighting specific concerns about the potential damaging 
impact of time in prison on young offenders. Nevertheless, in 
its focus on proportionality in its 2007 report, it emphasised 
that the measures listed in the conventions could be applied 
as ‘complete alternatives to conviction and punishment’ in 
minor personal possession cases (United Nations, 2008, 
para. 18). In March 2012, the representatives at the 
Commission on Narcotic Drugs (CND) drafting Resolution 
55/12, whose preamble recalled that the conventions provide 
for alternatives to conviction or punishment, went on to agree 
the main text which discussed ‘alternatives to prosecution or 
prison’, including community service and electronic tagging 
(Commission on Narcotic Drugs, 2012). In Europe, the EU 
Action Plans on Drugs 2000–04 (Action 3.4.2), 2005–08 
(Objective 13) and 2009–12 (Objective 7 and Action 16) all 
focused on the development and use of ‘alternatives to 
imprisonment’ as components of treatment objectives, while 
in the Americas, a 2013 proposal from the government of 
Colombia to the Inter-American Drug Abuse Control 
Commission (CICAD) led to the drafting of a ‘Technical report 
on alternatives to incarceration for drug-related offences’ 
(Inter-American Drug Abuse Control Commission, 2015).
The latest EU Action Plan on Drugs 2013–16 (Action 21) better 
reflects the original wording of the conventions, encouraging 
provision of ‘alternatives to coercive sanctions (such as 
education, treatment, rehabilitation, aftercare and social 
reintegration) for drug-using offenders’. At the most recent 
session of the Commission on Narcotic Drugs (2015), a draft 
resolution proposed by the United States referred to 
‘alternatives to incarceration’ but the text was finally agreed 
with the emphasis on ‘alternatives to conviction or 
punishment’. 
I What is an ‘alternative to punishment’? 
While ‘alternatives to conviction or punishment’ emphasises 
the aim of the policy response, ‘alternatives to prison’ 
emphasises the setting. Despite the two terms appearing to 
be used almost interchangeably, they are quite distinct.
The term ‘punishment’ has been defined for the purposes of 
this paper as ‘the intentional infliction of pain or of something 
unpleasant’ (by an authority, for breaking rules) (Peters, 1966) 
— a measure with a retributive aim. Imprisonment has 
retribution as a key purpose but there are many lesser 
penalties, such as fines, electronic tagging, or community 
imprisonment. This focus on deterrence and punishment was 
strengthened by the UN Convention against Illicit Traffic 1988, 
which (with safeguard clauses) specifically asks Parties to 
establish possession for personal use as a criminal offence. In 
2009, the UNODC reported that ‘Drug possession and sale 
are illegal in most countries of the world, and, as a result, the 
drug problem was long seen as primarily a criminal justice 
issue’ (UNODC, 2009). 
By comparison, little attention has been paid to the 
Article 36.1(b), inserted by the 1972 protocol to the 1961 
convention (and echoed in the 1971 UN Convention on 
Psychotropic Substances), which states that ‘when abusers of 
drugs have committed such offences, the Parties may provide 
… either as an alternative to conviction or punishment or in 
addition … that such abusers shall undergo measures of 
treatment, education, after-care, rehabilitation and social 
reintegration’. It is noteworthy that this uses the word 
‘abusers’, as distinct from ‘addicts’ in Article 38, above. 
Moreover, while much focus has been on the 1988 
convention’s requirement to establish personal possession as 
a criminal offence, it simultaneously widened the scope of 
application of rehabilitative alternatives or additions to 
conviction or punishment (in Article 3.4 (b–d)). This permitted 
the same measures of treatment, education, aftercare, 
rehabilitation and social reintegration to be an option for drug 
offenders in general, whether drug abusers or not, including 
for those who have committed minor supply offences. It also 
recognises that these need not be exclusively delivered by 
courts, suggesting ‘bridges between the criminal justice 
system and the treatment system might also be envisaged at 
other stages of the criminal process, including the prosecution 
stage’ (United Nations, 1998a, para. 3.108). 
However, between 1988 and 1992, the policy discussion on 
‘alternatives to conviction or punishment’, which were 
rehabilitative responses, largely metamorphosed into one on 
‘alternatives to prison’, at least in Europe, where the latter term 
was still used in the 2009–12 EU Drugs Action Plan (1). Both 
(1) The ‘Report on national programmes for drug demand reduction in the 
European Community’ of 8 November 1990 summarised legal responses to 
users as therapeutic and ‘an alternative to prison’, even while the annexed 
summaries of national reports only referred to alternatives to punishment. The 
first European Plan to Combat Drugs, of 10 December 1990, referred in section 
III, A, 2 (D) to the need to ‘promote the treatment and rehabilitation of drug 
addicts serving sentences for criminal offences by means of medical and social 
support in prison or in alternative systems to detention where they exist’, though 
its Annex 1 did refer to ‘applying measures alternative to punishment … as 
recommended by’ the 1988 convention. The subsequent ‘Resolution of the 
Council and the Ministers for Health, meeting within the Council of 11 November 
1991 on the treatment and rehabilitation of drug addicts serving sentences for 
criminal offences’ requested a systematic inventory of alternatives to prison but 
did not mention alternatives to punishment. The second European Plan to 
Combat Drugs, in 1992, only commented that ‘Most Member States have 
implemented measures to support drug misusers in prison, … and the offering of 
in-patient addiction clinic treatment as an alternative to imprisonment.’ There was 
no mention in the European Action Plan 1995–99, but following a conference on 
drug policy in 1995, the EMCDDA launched a study on ‘alternatives to prison’ for 
persons convicted of drug offences in 1997. ‘Alternatives to prison’ have then 
featured regularly in the treatment sections of EU action plans 2000–12.
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‘Alternatives to punishment’ are most commonly understood 
to be programmes of treatment targeted at problem drug 
users who enter the criminal justice system, using the threat 
of (more severe) criminal sanction if the treatment is not 
undertaken to the satisfaction of the authorities; a European 
Commission-funded project called this quasi-compulsory 
treatment (Schaub et al., 2010). Such treatment programmes 
have had a consistently high political profile in Europe during 
the last decade, under the EU action plans described 
previously and as a special focus of the Criminal Justice 
Forum of the Council of Europe’s Pompidou Group from 2007 
to 2010 (where the approach was called ‘quasi-coerced 
treatment’). Measures of ‘aftercare, rehabilitation and social 
reintegration’ would also be targeted at problem drug users, 
but there seems to be considerably less information on these. 
The EMCDDA recently published a detailed review of social 
reintegration programmes, defined as ‘any social intervention 
with the aim of integrating former or current problem drug 
users into the community’ and consisting primarily of housing, 
education and employment (EMCDDA, 2012). 
Yet ‘drug-using offenders’ also includes those who are not 
dependent or problem drug users, and these are usually the 
most numerous. In various countries in Europe, this group of 
offenders has been addressed through de facto or de jure 
decriminalisation (punishment without criminal conviction) or 
depenalisation (closure of minor cases) (EMCDDA, 2011a). 
Nevertheless, in some countries, there are some systems 
implemented where such offenders are given forms of 
‘education’, and these are included in this report.
Therefore, this paper addresses rehabilitative measures 
applied by the criminal justice systems in Europe that are 
usually oriented towards treatment or post-treatment 
interventions for problem drug users, or towards education for 
non-problem users. This is an artificial division of a continuum 
of drug-use behaviours, used here for ease of description, and 
it will be apparent at some points that certain responses do 
not easily fit under either heading. Similarly, when reporting on 
the different laws and papers, there are inconsistencies in 
vocabulary, such as drug user, abuser, problem user and 
addict, and the balance between harmonisation for ease of 
reading and accurate reporting of the original is a challenge. 
Generally, the paper tries to categorise the rehabilitative 
options in a flexible way proportionate to the level of problems 
measured in each user. The various ‘treatment alternatives to 
punishment’ that are specified in the national laws of the 
different Member States may be found online in the EMCDDA 
Legal database on drugs (ELDD). 
The measure may be given at any stage in the criminal justice 
system, whether by the court, the prosecution, or the police. 
The term ‘criminal justice system’ is used for simplicity, but 
refers also to non-criminal (civil, administrative) systems for 
sanctioning minor drug use or possession that are used in 
service that are also punitive. The ‘Handbook of basic 
principles and promising practices on alternatives to 
imprisonment’ (UNODC, 2007) observes that the caseload of 
the criminal justice system may be reduced by policies of 
alternatives to conviction (decriminalisation) and alternatives 
to punishment (diversion). A country may establish 
alternatives to conviction through a process of 
decriminalisation, but decriminalisation is understood as 
maintaining the punishment though outside the criminal law. 
The United Nations Standard Minimum Rules for Non-
custodial Measures (the Tokyo Rules) establish what such 
punishments (sanctions) may be: verbal sanctions, such as 
admonition, reprimand and warning; conditional discharge; 
status penalties; economic sanctions and monetary penalties, 
such as fines and day-fines; suspended or deferred sentence; 
and community service order (United Nations, 1990). While 
these penalties may be given as alternatives to conviction or 
prison — and are frequently given to drug law offenders in 
Europe (EMCDDA, 2009) — this report considers them as 
conceptually distinct from ‘measures such as education, 
rehabilitation or social reintegration … as well as …  treatment 
and aftercare’, and for this reason they will not be addressed 
here. 
Prison and many of the other punishments imposed through 
the criminal justice system may also have a rehabilitative 
element. Focussing on the term ‘alternatives’, this paper does 
not address measures that take place inside prison or 
following early release from prison. However, there remain 
other measures, difficult to classify, which have components 
of treatment or rehabilitation that may or may not be 
combined with punitive components such as probation 
orders, according to the judge’s instructions in each case. In 
many of the measures, some punitive element, such as the 
acquisition of a criminal record, some monitoring of behaviour 
or a fine, will be retained, while in some countries, the 
sentence is the order for treatment itself. Similarly, in many 
countries it is stated that the offender may receive a ‘warning’, 
and it is often not known how much these warnings are 
intended as a deterrent, reminding the offender not to break 
the law as he or she risks punishment, or as an early 
intervention, reminding the offender of the dangers of drug 
use present or future — or any combination of the two. Thus 
the extent to which the rehabilitative element is, strictly 
speaking, an alternative to punishment or an addition to it will 
vary. There is essentially a continuum of practice from a main 
focus on punishment, such as incarceration with or without 
some provision of rehabilitative services, to an emphasis on 
rehabilitation which may be supported by some degree of 
coercion. For simplicity we talk of alternatives to punishment 
and focus on that part of the spectrum that gives greater 
emphasis to rehabilitative measures; this was described by 
UNODC (2010) as a ‘health-oriented approach’ in contrast to 
‘a sanction-oriented approach’.
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under the influence of drugs. The main focus of these 
interventions is to encourage engagement in treatment. Here 
we consider the main alternatives that are utilised at the 
different stages of the justice process from arrest to 
sentencing.
Measures available to police
Arrest referral is a partnership initiative between police and 
local drug services that uses the point of arrest within custody 
suites at police stations as an opportunity for an independent 
drugs worker to assess drug users and refer them to drug 
treatment services if appropriate (Hunter, 2005). It has been 
established in the United Kingdom (England and Wales) at a 
national level since 2002, where it is not an alternative to 
prosecution or due process but a technique for engaging with 
users. A report on the UK system observed that arrest referral 
could be delivered using three models, based on information 
(providing leaflets), proactivity (involving specialist workers in 
the police stations), and coercion (cautioning an arrestee to 
seek advice from a drugs worker) (Sondhi et al., 2002). 
In the United Kingdom, arrest referral was later incorporated 
into the Drug interventions programme, which involved 
criminal justice and drug treatment providers working together 
with other services to provide a tailored solution for adults 
— particularly those who misuse Class A drugs — who 
commit crime to fund their drug misuse. Its principal focus 
was to reduce drug-related crime by engaging with 
problematic drug users and moving them into appropriate 
treatment and support (Home Office, 2011). The Drug 
interventions programme was introduced in high crime areas 
and involved combining arrest referral with drug testing on 
charge — and since 2005, drug testing on arrest. Under the 
programme, offenders over 18 in police custody could be 
tested for heroin or cocaine/crack if they were arrested for a 
trigger offence (offences such as burglary and theft that have 
been shown to be associated with problem drug use) or for an 
offence where a police officer of inspector rank or above 
suspects that use of drugs was a causal or contributory factor. 
There is a sanction for failure to be tested or to attend 
assessments. While national funding for the Drug 
interventions programme has been discontinued since April 
2013, many police force areas still operate a drug intervention 
initiative following drug testing on arrest. Most areas also 
continue to fund criminal justice intervention teams to 
proactively engage drug-misusing offenders following arrest 
(including areas without drug-testing initiatives).
In Ireland, arrest referral for juveniles was piloted in Dublin in 
2003. A new scheme was piloted for adults in 2012. 
Arrest referral was also piloted in Malta in 2005, though this 
had a low take-up. The scheme has recently been redrafted as 
some countries. Alternatives or additions to punishment are 
usually given as an option for the judicial authorities, but they 
may also be obligatory; for example, in Portugal, for a first 
offence it is obligatory to suspend proceedings. 
This paper addresses alternatives for adults only, as very few 
European countries choose to punish minors for drug use-
related offences (EMCDDA, 2003).
I Overview
I Legal mechanisms in Europe today
This section presents a brief overview of the alternatives or 
additions to punishment available in Europe today, examining 
the range and diversity of the various factors such as eligibility 
criteria, the types of offender involved, the aim and type of 
measure available (e.g. treatment, education) and setting, and 
the stages of the criminal justice system at which they may be 
invoked. Rehabilitative mechanisms used for problem drug 
users are discussed first, before moving on to those designed 
for other users.
I Rehabilitative options for problem drug users 
Alternatives or additions to punishment for problem drug 
users may be applied to individuals being dealt with for drug 
offences or in response to other types of offences that may be 
associated with drug use, such as acquisitive offences 
committed to obtain money for drugs, or offences committed 
Discussions on the topic of alternatives to punishment 
may use the following terms, and it is important that they 
are used consistently. EMCDDA preferred usage, as 
adhered to in this report, is as follows:
n  Decriminalisation — an alternative to conviction 
that is usually a punishment. 
n  Depenalisation — closure of minor criminal cases 
without punishment.
n  Alternatives to prison — measures that take place 
outside prison, which may be retributive or 
rehabilitative.
n  Alternatives to punishment — measures that are 
rehabilitative, such as treatment, education, aftercare, 
rehabilitation and social reintegration.
Terminology
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(Belgium, Czech Republic, Denmark, France, Luxembourg, 
Austria), or the offender may opt for treatment (Hungary, 
Poland). In the Czech Republic, this is according to a section 
of the Code of Criminal Procedure (s. 307–308) for any 
offence punishable by up to five years’ imprisonment. In 
Denmark, it is by a section of the Criminal Code (ss. 56–57), 
and there is no limit to eligibility in terms of offences. The 
mechanisms in Belgium, France, Luxembourg and Austria 
(ss. 35 and 37 SMG) have been outlined above and are 
applicable to the court as well as the prosecutor. In Hungary, 
section 180 of the Criminal Code, among those defining drug 
offences, states that no punishment shall be applied for drug 
addicts possessing a small quantity for personal use, provided 
the offender can produce before sentencing a document 
certifying participation in treatment or a preventative-
consulting service. A comparable mechanism, described 
above for prosecutors, is also available to the court in Poland 
under Article 73 of the main drug control law.
Suspension of punitive sentences by court is possible only 
after the conviction has been declared; a punishment may be 
declared but then it will not be carried out provided the 
offender successfully undergoes a rehabilitative course. This 
option is available in the Czech Republic, Estonia, Spain, 
France, Germany, Latvia, Luxembourg, the Netherlands, 
Austria, Slovakia and in some countries’ drug courts (see 
‘Drug courts in Europe’). A general article of the Penal Code 
provides conditional waiver of punishment for less serious 
offences if the offender consents to certain conditions 
including addiction treatment, psychological counselling or 
abstention from drug or alcohol use in the Czech Republic 
(s. 48), and abstention from drugs in the Netherlands 
(Article 14). In Estonia, the Penal Code allows substitution of a 
prison sentence of six months to two years by treatment if the 
original offence was caused by addiction (s. 692), while in 
Latvia, the Penal Code offers suspension of sentence (s. 55) 
and release from sentence (s. 59). In Spain, a Penitentiary 
Regulation of 1996 allows for voluntary treatment in 
institutions outside prisons (Article 182), which in practice 
often results in the offender agreeing to be sent to a 
therapeutic community, with freedom restricted accordingly. 
In Germany, the main drug control law (BtMG s. 35) allows the 
judge to defer execution of a sentence of up to two years’ 
imprisonment for addicts who undergo addiction treatment. In 
Luxembourg, again under the main drug law, the court may 
order treatment or rehabilitation as a protective measure and 
suspend the punitive sentence. In Austria, under s. 39 of the 
main drug law, it is mandatory (since 2008) for the court to 
suspend execution of the sentence for an addict who has 
been given a sentence of up to three years’ imprisonment for 
minor supply offences, if the offender is addicted and the 
treatment appears to have a chance of success. In Slovakia, 
protective treatment can be imposed by a court in a case of 
‘conditional suspension of sentence of imprisonment with a 
probation supervision’, following s. 51 of the Criminal Code. 
‘Arrest referral scheme and extra-judicial body for the 
processing of first time offenders for drug offences — 
possession for personal use’. As this is for first offenders with 
no previous convictions, it will be discussed in the section 
below for non-problem users.
Police in Portugal refer drug users, problematic or not, to the 
national network of commissions for the dissuasion of drug 
abuse (see ‘Ministry of Health in charge: the Portuguese 
model’).
Measures available to prosecutors
Suspension of proceedings by the prosecutor may occur prior 
to a decision to deliver a punishment or to pass the case to the 
court for trial. In some countries, the mechanisms of 
suspending proceedings against problem drug users can be 
applied only for offences of use or possession of drugs for 
personal use. This is the case in France (Public Health Code, 
Article L3423-1), Luxembourg (Law of 19 February 1973, 
Article 23), and Romania (Law 143/2000, Article 19). This 
would probably also describe the non-criminal procedures in 
Italy, where someone committing the administrative offence of 
drug use will be interviewed by the drug addiction operating 
unit of the local prefecture and may be sent to treatment, and 
in Spain, where the administrative sanction for drug use can 
be suspended if the offender applies to a treatment service as 
agreed (Ley Organica 1/92, Article 25).
By contrast, other countries offer alternatives to problem drug 
users even if they have committed other offences that might 
be connected with drug use. They are established in the main 
drug control laws in Belgium (AR 1930, Article 26), Greece 
(Law 3459/2006, Article 31) and Austria (SMG, s. 35). They 
are established in more general criminal laws in Latvia 
(Criminal Code, Article 58.1) and the Netherlands (Code of 
Criminal Procedure, Article 80). 
There is a variation of this approach in Poland, where the 
initiative to seek treatment is with the offender, rather than by 
instruction of the prosecutor. Article 72 of the main drug 
control law in Poland gives prosecutors the right to suspend 
proceedings against a problem drug user for any offence 
punishable by up to five years in prison, if the offender enters a 
relevant treatment or prevention programme in a healthcare 
centre. 
Measures available to courts
Suspension of proceedings by the court before passing 
judgement (and, usually, conviction) is a mechanism available 
in many European countries. Normally with the consent of the 
offender, the court may require attendance at treatment 
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Treatment without consent is often a judicial option for 
offences committed under intoxication, and may be used to 
impose ‘protective’ measures, protecting either the individual 
or the general population. These mechanisms are available in 
many countries in Europe (Bulgaria, Czech Republic, 
Denmark, Germany, Spain, Croatia, Lithuania, Netherlands, 
Slovakia, Sweden). They may have a historical perspective, 
coming from a viewpoint of addiction as a mental illness that 
would lead to institutionalisation; though in Spain for example 
it is regulated in the Civil Code and applies to any person 
whose physical condition could be a risk to the general 
population. While outside the prison system and staffed 
predominantly by health professionals with a rehabilitative 
aim, they will normally be in closed treatment structures and 
thus subject to application of the right to liberty in the 
European Convention of Human Rights. Such systems remain 
controversial; in less developed countries they may effectively 
be compulsory detention systems, with little efficacy in 
treating addiction and scant regard for human rights (Hall et 
al., 2012). In at least some of the EU countries listed above, 
they seem to be used very rarely: in the Czech Republic, 3 % of 
drug law offenders in 2010; Lithuania, five of 1 346 offenders 
in 2010; in the Netherlands, the Institution for Prolific 
Offenders has about 400 addicted offenders attending each 
month. The UNODC has clarified that treatment without 
consent should be used to treat an acute medical or security 
Specialised drug courts may be used as a mechanism for 
administering this sort of approach (see ‘Drug courts in 
Europe’).
Sentencing to rehabilitative measures is possible following 
court conviction in France, Croatia, Sweden, the United 
Kingdom and Norway. In France, the mechanism described 
above for the prosecutor in the Public Health Code, 
Article L.3425-1, is also available as a sentence, and in the 
United Kingdom the court may sentence a dependent 
offender, or one with a propensity to misuse drugs, to a drug 
rehabilitation requirement (usually additional to a community 
order). In Croatia, under the Law on Combating Drugs Abuse 
(Article 10), an offender who is addicted to drugs or is an 
experimental drug user will be given a measure of obligatory 
treatment in a medical or social care institution, lasting from 
three months up to one year, while the Criminal Code urges 
the court to use treatment measures for appropriate cases 
when a prison sentence of up to six months is prescribed. In 
Sweden and Norway, offenders may be sentenced to 
probation according to the Penal Code, and some 
requirements of the probation order may be to attend a drug 
treatment course. 
A drug court is a specialised court that deals with criminal 
offenders who have drug addiction and dependency 
problems (USGAO, 2011), a concept first developed in the 
United States in the late 1980s. Underlying the model is the 
belief that problems associated with drug-related offending 
behaviour may require social or therapeutic rather than 
legal solutions (Kerr et al., 2011). The courts are distinct 
from normal courts in that they tend to incorporate multi-
agency partnerships, with the criminal law judiciary aiming 
to play more of a health management than deterrent or 
retributive role, in partnership with a team of correctional, 
health and welfare professionals. The courts generally do 
not carry out trials to determine guilt or innocence; many 
drug courts require the offender to plead guilty to the 
drug-related offence before he or she is allowed to enter the 
drug court programme, so offenders enter at the sentencing 
stage (though the Glasgow Drug Court in Scotland can 
accept cases referred from police custody). The court then 
supervises the offender going through a treatment 
programme; given the guilty plea, the court uses the threat 
of custodial sentencing to encourage participation in and 
completion of the treatment programme.
In Europe, drug courts have been established as local pilot 
projects in Dublin, Ireland in 2001; in Glasgow and Fife, 
Scotland in 2001/2; in Leeds and West London, England in 
2005, followed by Barnsley, Bristol, Salford in 2009, 
together with Cardiff, Wales; in Oslo and Bergen, Norway; 
and in Ghent, Belgium in 2008. 
Aside from the partnerships, shared features of these 
include continuity of the judiciary throughout the 
programme (one of five judges in Norway), limitations on the 
seriousness of the offender eligible (non-violent in Ireland 
and Scotland), and the aim to avoid prison. Drug courts in 
Europe are not for first-time offenders, but will require the 
offender to have some form of serious drug misuse and 
related criminal behaviour. As pilots, the courts are limited 
to offenders residing in a certain catchment area. In the 
Norwegian model, for legal reasons, there is less 
involvement of the court in the programme (the judge is not 
part of the team and there will be no pre-court meetings), 
though it is the court that takes the decisions regarding 
offender progress or sanctioning. All these projects have 
been subject to evaluation, following which the decision has 
been taken to continue the pilots.
Drug courts in Europe
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officer or prosecutor may be considered a deterrent or as 
counselling.
Users in Italy will be interviewed by the prefecture and then 
may be sent to a local public drug addiction services unit to 
complete a rehabilitation programme. In Croatia, Latvia and 
Luxembourg, the mechanisms described above for 
problematic users also apply to ‘users’. In France, a ‘drugs 
awareness course’ was established as an option in 2007 to 
ensure that the criminal justice system, most commonly the 
prosecutor, has a constructive and proportionate response to 
occasional, non-problem users, when the previous response 
may have been to simply dismiss minor cases or give a 
criminal conviction. The offender has to pay the cost of the 
course, which is usually around EUR 250 euros but cannot be 
more than EUR 450. This may thus be interpreted as a 
combination of measures, with both rehabilitative and punitive 
effects.
Variations of the Portuguese model (see ‘Ministry of Health in 
charge; the Portuguese model’) for non-problem users are 
under discussion in Scandinavia and Malta. In June 2011, the 
Stoltenberg Commission in Norway recommended that 
persons arrested for minor drug offences be offered 
motivational interviews or a more long-term intervention 
programme with the aim of rehabilitation, as a special 
condition in a conditional waiver of prosecution or conviction, 
based partly on the Portuguese model. In Malta, the newly-
redrafted arrest referral scheme is to work in partnership with 
an ‘extra-judicial body’, consisting of a chair and two experts 
in the field of drug use. First offenders (with no criminal 
record) arrested for possession of a small amount of drugs for 
personal use are to be offered the option to attend the 
extra-judicial body and follow its directions; while this is done, 
the prosecution is suspended. In July 2014, a white paper was 
published on this (Times of Malta, 2014), resulting in the Drug 
Dependence (Treatment not Imprisonment) Bill. Motivational 
interviewing has also been implemented for young offenders 
in Finland; a multi-professional reprimand involving the 
guardian, a representative of the social welfare authorities and 
the police, in which the offender’s life situation is examined, is 
considered a more effective sanction than a fine.
In other countries, prevention and education responses 
primarily designed for juveniles may also be used for young 
adults. In Germany, the programme ‘Early intervention in 
first-offence drug consumers — FreD’ is mainly aimed at 14- 
to 18-year-olds, but individuals up to age 25 are eligible. Such 
local prevention measures are used as a possibility to 
intervene without starting criminal proceedings right away. 
This programme has been promoted in several European 
countries under the title ‘FreD goes Net’, with results regularly 
reported by Cyprus. In Luxembourg, minors and young adults 
who have come into conflict with the law for drug-related 
offences may be referred to a youth solidarity team (Project 
emergency, and should cease once the acute emergency has 
been avoided; long-term residential treatment without consent 
is a form of incarceration (UNODC, 2010). 
I  Rehabilitative options for other (non-problem) drug users
Some countries have options for alternatives to punishment 
available to non-problem users (though the majority appear to 
opt for policies of decriminalisation or depenalisation, either 
with non-criminal punishments or simply closing the case as 
minor). According to the legal frameworks, users without any 
diagnosis of addiction, who commit minor drugs possession 
offences, may be eligible for diversion to some form of 
counselling or rehabilitation course (France, Croatia, Italy, 
Latvia, Luxembourg, Portugal). These are sometimes 
considered as indicated prevention measures. As mentioned 
earlier, it is not known to what extent a warning by a police 
The Portuguese Drug Strategy of 1999 proposed a 
change in direction to an approach based on ‘humanism 
and pragmatism’, removing the threat of criminal 
punishment to encourage the most problematic addicts 
into treatment. This involved decriminalisation of use-
related offences, making them administrative offences, 
and establishing ‘commissions for the dissuasion of drug 
abuse’ (CDT) in each of Portugal’s 18 districts to deal 
with the offenders. Distinct from drug courts, the CDTs 
are under the auspices of the Ministry of Health, and are 
multidisciplinary panels composed of a lawyer, a doctor 
and a social worker who meet the offender around a 
table, rather than a judge in a courtroom. All drug users 
stopped by the police will be sent to a CDT, whether they 
appear to be experimental users or dependent ones. No 
guilty plea is required and there is no threat of prison; 
sanctioning by fine, the maximum possible punishment, 
is an available option for non-addicts but the institutional 
philosophy means it is not the main objective in this 
phase. Based on the case assessment by a small team 
of practitioners who will have similar professional 
backgrounds to the members, the CDT hears the 
offender and rules on the offence, aiming to treat any 
addiction and rehabilitate the person using the most 
appropriate interventions. The CDT is authorised to 
suspend the proceedings or the execution of a punitive 
sentence as it considers appropriate.
Ministry of Health in charge: the Portuguese 
model
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review of the EU Drugs Action Plan 2005–08 stated 
‘quantitative data on the use and effectiveness of alternatives 
to prison are generally not available’, and a 2009 report on 
sentencing and other outcome statistics observed ‘it is 
strange that referrals to treatment through the legal system 
are barely visible in the data provided’ (EMCDDA, 2009). 
However, some data sources indicate that the alternatives are 
being used: EMCDDA treatment demand data showed that, 
across Europe, 20 % of the 147 000 new clients reported to 
have entered outpatient treatment in 2010 (and 7.5 % of the 
nearly 9 000 new clients entering inpatient treatment) were 
referred from courts, probation services or police. These 
numbers will not always be matched by those in judicially 
supervised treatment, as it is known that some (but usually an 
unknown proportion) are referred less formally, without any 
judicial intention to monitor the outcome. Thus it appears that, 
across Europe, a considerable number of offenders are 
diverted from the criminal justice system, with little monitoring 
of this approach.
In the absence of a comprehensive picture of coverage across 
Europe, this report will provide instead some illustrations of 
the extent to which alternatives to punishment are being used 
in some countries, before describing some of the issues that 
impact on their implementation. 
In Portugal, in 2012, 82 % of CDT rulings suspended the 
process temporarily, 15 % were punitive rulings and 3 % found 
the defendant innocent. These primarily involved cannabis 
offences, though cocaine is becoming more visible in the 
statistics. The numbers of offences involving heroin were 
lower than in previous years. In recent years, around 60–65 % 
of suspensions are for users considered non-addicted, while 
15–20 % are suspended due to the user agreeing to undergo 
treatment. Punitive rulings are usually non-monetary, ordering 
the offender to report periodically to a chosen location.
In Italy, in 2012, 13 660 offenders were interviewed by drug 
addiction operating units after committing the administrative 
offence of possessing drugs for personal use. However, legal 
changes in 2006 appear to have had significant effects on 
how they are dealt with. Before the change, the offender could 
start a rehabilitation programme as an alternative to the 
administrative penalty, but under Law 49/2006 the 
administrative penalty is applied and completed before any 
offer of a rehabilitation programme, reducing the incentive to 
take this option. For this reason, the numbers opting for 
rehabilitation have fallen from over 10 000 per year before the 
change to less than 300 in 2012. Also in 2012, proceedings 
against 1 559 offenders were closed following successful 
completion of prescribed treatment programmes. In contrast, 
a different law, also introduced in 2006 (Law 241, the 
Collective Clemency Bill), applied to the criminal justice 
system. This law reduced sentencing and accelerated the 
possibility of benefiting from alternative measures. The 
IMPULS), financed by the Ministry of Health; annual statistics 
show that about 18 % of the 300–400 referrals each year are 
aged 18 or over. The team may be considered a crisis situation 
manager who report progress back to the requesting authority.
These mechanisms may be represented schematically in 
Figure 1.
In summary, outlining the various factors set out in the legal 
stipulations and accompanying guidelines reveals a wide 
variety of non-punitive measures around Europe. In part, these 
differences in design may stem from differences in the legal 
and judicial contexts and also in the drug situations between 
countries, which may influence the legislators’ objectives. 
I  Coverage, implementation and common issues
I Coverage
While the previous section showed that many countries have 
legal provision for alternatives or additions to punishment, the 
extent to which they are used is unclear. A 2007 progress 
FIGURE 1
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In the United Kingdom, interventions vary by constituent 
countries. The Drug interventions programme (until 2013) was 
the main method of engaging drug-using offenders with 
treatment services in England and Wales outside the prison 
system, delivering tailored combinations of rehabilitative and 
punitive measures; similar local initiatives still exist but it is 
now down to local areas to take decisions on the approach 
best suited to meet their local need. In England, around 
88 000 individuals were helped into drug treatment (including 
non-structured treatment) and recovery services in 2011/12; 
treatment data show 8 881 adults entering structured 
treatment from arrest referral or through the Drug 
interventions programme. In Wales, there were 3 907 referrals 
to the Drug interventions programme. The drug rehabilitation 
requirement within a community order or suspended sentence 
of imprisonment involves treatment, regular testing and court 
reviews of progress, and is subject to rigorous enforcement. In 
2012, 13 283 drug rehabilitation requirements were 
commenced, 9 284 as part of a community order and 3 999 
as part of a suspended sentence order. The number of drug 
rehabilitation requirement commencements has fallen around 
20 % from 2009, partly due to police initiatives which divert 
offenders at charge and partly due to a change in focus from 
number who have benefited has steadily increased since 
2007; in 2012, some 2 518 drug addicts were put on probation 
or released into the care of social services. 
In Austria, most prosecutor and court decisions regarding 
drug possession offences are clearly recorded, allowing for 
the analysis of trends in the use of the alternatives to 
punishment (see Figure 2). Between 2004 and 2013, there 
has been a considerable increase in temporary 
discontinuations of penal action by the public prosecutors in 
cases involving exclusively personal use of cannabis, 
hallucinogenic mushrooms, or substances classed as 
psychotropic, and where there were no similar reports against 
the offender in the last five years (SMG Section 35 para. 4). 
There are now more of these than other cases of temporary 
discontinuation of penal action under SMG Section 35 (excl. 
para. 4) since 2012, possibly influenced by the rise in 
cannabis-related reports to the police. Overall, in 2013, 86 % 
of diversion offers were initiated by the public prosecutors. 
The same period has also seen a general rise in suspension of 
sentence under the principle of treatment instead of 
punishment (SMG Section 39), which is usually for opioid 
problems. 
FIGURE 2
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an extra-judicial body, but at present eligibility is strictly 
limited to first offenders with no criminal record. 
This latter criterion effectively made the provision of treatment 
as an alternative unusable in Poland. Since 1997, under Article 
72 of the main drug control law, the prosecutor could suspend 
proceedings for an offender with no previous convictions who 
enters treatment. No official figures are kept, but a study in 
2008, looking at 300 cases over three years and interviewing 
prosecutors, users and prisoners, concluded that this option 
was rarely implemented. While 95 offenders were diagnosed 
as problematic users, and 47 declared willingness to enter 
treatment, only 9 had no previous convictions, and ultimately 
not one of the 300 cases was suspended based on Article 72 
(Serednicki, 2009 cited in the 2011 Reitox national report). As 
a result, this requirement of no previous convictions was 
abolished in 2011, and the prosecutor and judge are now 
obliged to collect information on the offender’s drug use, 
rather than simply having the option to do so as previously.
Assessment of eligibility
The examination of countries’ legislations above shows that 
rehabilitative measures for drug-using offenders via the 
criminal justice system exist in a wide range of formats but 
with different criteria for eligibility. As a first step in 
implementation, there is already variation between European 
countries when it comes to establishing the diagnosis of 
addiction. An informal questioning of the ELDD’s legal 
correspondent network in 2011 revealed that in eight of the 17 
countries answering, such diagnosis was made by court-
appointed experts or specialist court staff (Czech Republic, 
Spain, Croatia, Poland, Portugal, Slovakia, Sweden, Norway). 
In contrast, in five countries it was made either in a treatment 
centre (Estonia, Latvia, Romania) or in a hospital (Hungary, 
Turkey). The offender could be examined by a panel of three or 
more experts in five countries (Estonia, Latvia, Luxembourg, 
Portugal, Romania), by a pair of experts in the Czech Republic 
and Slovakia, and by a single expert in the remaining countries 
(Belgium, Spain, Hungary, Austria, Poland, Sweden, Norway). 
These experts may be general practitioners, psychiatrists, 
psychologists, social workers or other addiction experts; in 
Luxembourg and Portugal a jurist is a member of the panel. 
Assessments may be single-step or multi-step, with a rapid 
screening later followed by a more in-depth examination and 
tests, and may last from one hour to several, with the 
exceptional possibility of longer-term monitoring in a medical 
institution for up to two months (Slovakia). A more detailed 
assessment of these processes might determine whether or 
not they also include elements of assessment of motivation 
and treatment need.
The EU’s research project on ‘quasi-compulsory treatment’ 
looked in more detail at the process and effects of treatment 
commencement to completion targets. To put these numbers 
in perspective, 2012 saw about 70 000 cannabis warnings, 
15 000 penalty notices for disorder and 39 000 cautions 
issued by the police for drug offences, and another 21 000 
fines issued by the magistrates’ courts. In Scotland, in 
2011/12, 158 probation orders commenced with a condition 
of drug treatment/education, and 557 drug treatment and 
testing orders were made.
I Implementation issues
Although any particular measure may be made available to the 
judiciary in the legislation, there is no guarantee that it will be 
widely used, or that it will be implemented and perform as 
originally designed. Monitoring a policy intervention to assess 
performance is particularly important — and challenging. This 
can be complicated by the fact that responsibility may lie 
within two spheres of public administration, in this case the 
health and justice sectors, which have traditionally differing 
views as to priorities and solutions. This section addresses 
some of the more common findings and issues.
Support for legislation
A few countries have had difficulty implementing their legal 
provisions on rehabilitative measures, in some cases because 
of difficulties relating to perceptions of leniency to criminals. In 
Cyprus, the law 57 of 1992 on ‘the care and treatment of 
addicts’ remained unimplemented in 2013, due in part to what 
have been referred to as ‘anachronistic and non-viable 
stipulations’. In Romania, the possibility of referral of a drug 
user to treatment with eventual suspension of the 
proceedings, established by the drug control law of 2004, was 
dependent on a new Criminal Code that was only passed in 
2009, and a new Criminal Procedural Code that was not yet 
passed in 2012; the new Criminal Code of February 2014 
finally removed the need for the Criminal Procedural Code. 
Initial support in Norway for a similar system to the 
Portuguese model, proposed by the Stoltenberg Commission, 
has weakened as the decriminalisation aspect has been 
considered too controversial to implement. In Finland, the 
Prosecutor General published guidelines in 2006 encouraging 
prosecutors to waive charges for drug users who have sought 
treatment (notably accepting that treatment, and thus waiver, 
may be required several times to break an addiction). However, 
it is reported that drug users usually receive fines rather than 
waivers, and the available statistics show that barely 8 % of 
those waivers were the result of referral to treatment. In Malta, 
an arrest referral scheme was piloted in 2005, but in the first 
five months, out of 212 people arrested for possession, only 
15 were referred to drug agencies by the police and the 
scheme fell into disuse. There is now a proposal to restart it, 
taking some cues from the Portuguese model by diversion to 
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sufficient extent. This coordination does not depend solely on 
collaboration between the treatment and justice systems, but 
is dependent on broader systems, such as welfare and 
healthcare funding, for its success. For a variety of reasons, 
best fit between client needs and treatment offers are not 
always guaranteed’ (Soulet and Ouveray, 2006). This was 
illustrated by the observation from Sweden that ‘some 
municipalities categorically denied all forms of treatment in 
spite of the fact that the Swedish Prisons and Probation 
Service financed the major part of treatment. Clinics offering 
medically assisted treatment also commonly refused to 
accept patients from the prisons and probation service, 
referring to the fact that they already had long lines of addicts 
outside the correctional treatment system in acute need of 
treatment’. 
This mismatch of client needs and treatment offers may also 
occur when the rehabilitative options are limited. For example, 
in 2002 it was reported that, in Austria, public health officers 
would prescribe obligatory health-related measures to 
cannabis users, leading to capacity and resource problems in 
the drug help centres which would hinder their core tasks. 
Monitoring or evaluation of programmes that include such 
mismatched options may indicate poorer than expected 
results, masking any evidence of effectiveness for those 
groups for which the programme is more suitable; options 
need to be appropriate to those to whom they are being 
applied. Some countries are taking steps to remedy this by 
offering a wider range of responses. For example, in France 
drugs awareness courses were introduced for minor cannabis 
offenders, as a more suitable alternative to the ‘therapeutic 
injunction’ designed years before for heroin users. Yet this new 
measure has also suffered implementation issues. An 
evaluation carried out by the French Monitoring Centre for 
Drugs and Drug Addiction (OFDT) in 2012 found that the use 
of the courses had been modest to date; about 4 500 courses 
were awarded annually, while over 120 000 people had been 
stopped for cannabis offences in 2010 (Obradovic, 2012). 
There was little consistent application of these nationwide, 
both in terms of the number of courses awarded and the costs 
charged to the users. 
In summary, key factors that appear important for 
implementation of rehabilitative measures through the 
criminal justice system are:
n  the framing of the legal provisions, particularly those that 
affect who will be eligible;
n  support from the criminal justice system, including the 
judiciary, and the public; 
n  the provision of a range of alternative rehabilitative 
provisions that will be appropriate for all the groups of 
offenders to which they will apply;
n  adequate resourcing so that sufficient places will be 
available for all those eligible;
options stemming from a judicial response to an offence in six 
European countries (2). The project found that entry to such 
programmes could be analysed in terms of three interactive 
processes (‘opportunity, eligibility and diagnostic’), which 
ultimately influence the quality of the placement and hence 
the outcomes (Soulet and Ouveray, 2006). The eligibility 
process, in terms of how the offender fits the administrative 
criteria of eligibility (e.g. addict or not, type of offence 
committed, severity of offence committed) has been touched 
on in the descriptions of the mechanisms above. One of the 
main criteria for the eligibility of an offender will be their level 
of drug dependence or other problematic drug use. It will be 
for the judiciary, following specialist advice, to decide the 
eligibility of each offender. This decision could impact on the 
final outcome, where offenders directed to more appropriate 
interventions are more likely to ‘succeed’. The opportunity 
process lies partly with the offender and partly with a 
professional, who may each decide whether or not they 
consider the offender ‘ready’ to seriously engage with a 
treatment process at that time. While this ‘readiness’ has 
sometimes been expressed in terms of ‘motivation’, the 
Quasi-compulsory treatment (QCT) Europe project and the 
Multi-site adult drug court evaluation (MADCE) in the United 
States both questioned the concept of ‘motivation’; MADCE 
found that ‘the construct of motivation may not necessarily be 
a good predictor of who will ultimately succeed in drug court’ 
(Rossman et al., 2011), while QCT Europe reported that ‘The 
concept of motivation was replaced with what emerged as the 
more pertinent concepts of commitment and commitment-
enabling conditions’ (Soulet and Ouveray, 2006). Finally, the 
diagnostic process aims to match treatment needs and 
treatment offers, considering not only types of treatment and 
implications for life situation, but also constraints on 
availability of particular options, such as waiting lists and 
funding restrictions. 
Matching offenders and needs
The 2009–12 EU Action Plan on Drugs (EUAP) objective of 
enhancing the effectiveness of treatment and rehabilitation 
translated into a number of actions, one of which included the 
further development of ‘effective alternatives to prison for 
drug-using offenders’. This objective of effectiveness 
encouraged a better match between offender need and the 
intervention available, in order to achieve higher success 
rates. The QCT Europe project found that the three interactive 
processes described above (opportunity, eligibility and 
diagnostic) often reveal problems in coordination between 
systems, and between client needs and treatment offers. ‘An 
assessment of needs and the selection of appropriate 
services is a focal point in the collaboration between key 
actors, but this crucial step is not always appreciated to a 
(2) England, Germany, Switzerland, Italy, Austria, Netherlands.
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(McSweeney, 2008). Setting such guidelines is a complex 
undertaking; for example, at what threshold should the 
supervising authority consider that a positive drug test or a 
new crime justifies termination of the alternative and 
reinstatement of the punitive procedure if progress is being 
made in other areas? An evaluation of pilot drug treatment and 
testing orders in Scotland concluded that ‘the incidence of 
positive drug tests for opiates decreased with time and 
reported expenditure on drugs decreased from an average of 
GBP 490 per week pre-sentence to an average of GBP 57 per 
week after six months on an order’ (Eley et al., 2002). Is such 
an outcome to be considered a success, given the massive 
reduction in expenditure, or a failure as the offender is still 
buying drugs? If an offender no longer tests positive for 
opioids, the disproportionate source of much individual and 
societal harm, but continues to test positive for cannabis, 
should they be encouraged or punished? 
It has already been established that there may be hesitance in 
the use of alternatives to punishment generally. However, 
well-meaning emphasis on high entry rates for treatment to 
stimulate greater use of such measures can encourage 
inclusion of those unsuitable for the particular intervention 
offered. Unfortunately, this in turn lowers the rates of 
successful outcomes and thereby damages the reputation of 
rehabilitative solutions as a viable response to offences. 
One of the most basic ways to evaluate effectiveness is by 
considering completion rates for programmes. A more 
advanced criterion for evaluation, though more challenging to 
implement, is to use reoffending rates and changes in drug 
use behaviours.
I Measures of effectiveness
Completion rates
The mid-term evaluation of the EU Action Plan on Drugs in 
2007, based on the structured questionnaires submitted to 
EMCDDA the previous year, found that percentage completion 
rates were available for some of the treatment ‘alternative to 
prison’ options in Ireland, Spain, Italy, the Netherlands, Austria 
and the United Kingdom. The majority of the other European 
countries had no information to answer this question, and few 
countries tracked all those who had been diverted to various 
treatment options. Thus the evaluation concluded that ‘A wide 
variety of alternatives to prison for drug-using offenders 
already exists, however it [is] not yet possible to assess their 
use and/or effectiveness’ (European Commission, 2007). 
Replies to a second round of questionnaires in 2009 showed 
little change.
n  good coordination and the cooperation of all those who will 
be involved in providing the alternative options; and 
n  monitoring the implementation and outcomes and making 
adjustments where necessary.
I Evaluation
I Evaluation: what do we know about what works?
Several rehabilitative options appear to be better in terms of 
efficiency, efficacy, or both, than punishment by itself, or at 
least less harmful, particularly where the punishment involves 
a prison sentence. However, obtaining clear scientific proof of 
this can be challenging and this is reflected in the 
comparatively small number of evaluations available (with the 
exception of drug courts). The evaluations themselves may 
have limitations that are not made clear, such as a pre/post 
evaluation having no comparison group, or accepting self-
reported behaviour without objective verification. In turn, this 
makes it difficult for policymakers to assess whether a 
measure is successful, could be improved, or should be 
abandoned. With little basis to state with confidence ‘what 
works’, this section considers some of the issues that emerge 
from the studies that have been undertaken and highlights 
lessons for evaluation design, with the aim to encourage 
legislators and practitioners to work towards producing more 
robust evaluation results in future.
Challenges in measuring success
The existence of multiple objectives may provide a challenge 
for evaluators to conclude whether or not a measure ‘works’ 
and adds to the difficulty of making comparisons between 
alternative approaches. Evaluations may use differing criteria 
to assess a variety of outcomes (drug-free or drug reduction, 
treatment completion or social reintegration, reducing 
reoffending or reducing drug use) over different time periods, 
and so can end up with ambiguous conclusions, depending on 
the priority given to different outcomes. 
The potential for contradictory assessments is illustrated in 
the two perspectives that can frame renewed drug use by a 
drug-dependent offender; the judicial perspective of 
recidivism (signifying failure and suggesting a punitive 
response) and the medical perspective of relapse (signifying 
chronic disease and indicative of the need for more intensive 
support). In a survey carried out by the Council of Europe’s 
Pompidou Group in 2008, the majority of countries answering 
had treatment standards or guidelines specifically drafted to 
implement a treatment programme under criminal justice 
supervision, and acknowledged the challenges in this field 
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positive for drugs when charged, found that the volume of 
offending was 26 % lower overall in the six months post-
intervention than the same period pre-intervention. 
Reoffending had fallen by 79 % for around half the cohort, but 
offending levels actually increased for about one quarter 
(Skodbo et al., 2007). Other impacts on recidivism are 
discussed in the drug court evaluations, below.
Impact on drug use
Only France has reported a study evaluating the outcome of 
the measure on drug use behaviour. The 2012 evaluation of 
drugs awareness courses, questioning 4 000 participants, 
found that the courses had a limited impact on cannabis use 
behaviours, partly as they were ‘not sufficiently personalised’. 
One-fifth of users stated they would not change their 
behaviour (except to avoid being caught again), and although 
two-thirds said they would stop or reduce consumption, the 
majority of those had started to reconsider their behaviour 
immediately following arrest, before the course started 
(Obradovic, 2012).
I Evaluations of drug courts
Drug courts are considered separately here as these have 
been the subject of a number of evaluation studies. The 
completion rates for drug courts in Europe, given below, 
appear quite low, with consequent high-level criticisms of their 
value for money. An example of this is the statement in 2009 
by the Secretary General of the Department of Justice to the 
Public Accounts Committee of the Irish parliament: ‘I am 
disappointed with its low output … the production level of the 
court does not justify extending the model elsewhere. It is not 
working and we must go back to the drawing board’ (Rabbitte, 
2009). Yet recent detailed process evaluations of the drug 
courts in Belgium, Ireland and the United Kingdom suggest 
that completion rates may not be the best outcome indicators. 
In Ireland, the drug treatment court was evaluated in May 
2010 (Department of Justice, Equality and Law Reform, 
2010). Over eight years, 374 offenders were referred to the 
drug treatment court, of whom 174 (47 %) were found to be 
unsuitable for the programme during the assessment phase, 
and only 29 participants (14 %) graduated from the 
programme. Nevertheless, participation was seen to have had 
a positive effect on participants’ behaviour, significantly 
reducing offending, even if they ultimately failed to complete 
the programme (Ward, 2011).
Key statistics and stakeholder views of the two drug courts in 
Scotland were collected in 2009 (Community Justice Services 
Division of the Scottish Government, 2010). In the period 
2004–08, around 50 % (Glasgow) and 75 % (Fife) of 
Some other completion rates have been reported in the 
national focal point reports or the structured questionnaires. 
In Austria, in the context of the QCT Europe project in 2005, 
about 57 % of clients referred to treatment from the justice 
system completed the therapy. In Sweden, data from the 
criminal register show that about 75 % of those starting 
probation combined with treatment contracts follow through. 
In the United Kingdom, various alternatives are monitored. In 
England and Wales, 55 % of drug rehabilitation requirements 
(nearly 7 000 in number) were successfully completed in 
2012/13. The completion rate has doubled since 2003. In 
Wales in 2009/10, 3 144 Drug interventions programme cases 
were closed; of these, 28 % of closures were due to treatment 
completion, 44 % due to client disengagement and 18 % were 
transferred to prison (10 % not reported). In Scotland, the 
proportion successfully completing drug treatment and 
testing orders increased from 40 % in 2008/09 to 54 % in 
2011/12.
In Italy and Finland, some more limited figures were available. 
In Italy, during 2012, administrative proceedings against 1 559 
persons were dismissed as a result of their having completed 
their prescribed treatment programmes. In Finland, in 2009 
there were 137 cases of community service sentencing (a 
broad label that includes various interventions) for which the 
main crime was drug-related. The community service was 
successfully concluded in 114 cases and resentenced as 
unconditional in 23 cases. The national focal point reported 
that resentencing was as common in drug-related cases as 
with other crime types.
Recidivism
Research into drug treatment and testing orders in England 
and Wales (3) suggested that offenders who completed orders 
had much lower reconviction rates (53 %) than those who did 
not (91 %), though it was not possible to attribute the 
difference entirely to the effect of the order (Hough et al., 
2003). One study used data from the Home Office’s Offenders 
Index to assess outcomes of those subject to drug treatment 
and testing orders in one area in England between 2000 and 
2002 (Powell, 2011). Data showed that the mean number of 
convictions per offender decreased from 12.0 in the two years 
before the start of the order to 9.4 in the two years after the 
start of the order. Overall, 61 % of the offenders had fewer 
convictions in the two years after starting treatment 
compared with the same period before, 7 % showed no 
change and 33 % had more convictions in the two years after 
starting treatment (total 101 % due to rounding). In line with 
this, research into the subsequent Drug interventions 
programme, following a cohort of 7 727 offenders who tested 
(3) In England and Wales, the drug treatment and testing order was replaced by 
the drug rehabilitation requirement for offences committed after April 2005.
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courts, observed that more frequent drug users showed a 
more marked reduction in use, and offenders with violent 
histories showed a greater reduction in crime (Rossman et al., 
2011). The net impact of cost savings was ‘driven by a 
reduction in the most serious offending by relatively few 
individuals, not by a widespread reduction of serious 
offending’. It therefore recommended consideration of 
including violent offenders with substance use issues — the 
same offenders who would normally receive punitive rather 
than rehabilitative sentencing. Nevertheless, a review by the 
US Government Accountability Office (GAO) found that the 
Bureau of Justice Assistance had still not documented 
standard or comparable methods to determine that the drug 
court measures were successful (USGAO, 2011). Finally, a 
2011 study of those entering state prison in 2004 or jail in 
2002 found that very few would have been eligible for 
diversion through state drug courts, questioning their value as 
a measure to reduce incarceration (Pollack et al., 2011). 
In summary, evaluation studies highlight that clarity about the 
objectives of the intervention is important, as is ensuring that 
interventions are targeted to the appropriate groups of 
offenders. Measures of recidivism and behavioural change will 
deliver important quantitative results, while parallel qualitative 
evaluation can be instrumental in highlighting the key areas to 
focus on for policy improvement. 
I Conclusions
Forty years ago, the international drug control legal framework 
established the rehabilitative options of treating, educating or 
reintegrating drug users as alternatives or additions to 
conviction or punishment; in contrast, the commonly used 
expression ‘alternatives to prison’ has no basis in the UN drug 
conventions and more narrowly focuses on the setting rather 
than the aim of the response. Returning the focus to the 
original policy, which is echoed in the EU Drugs Strategy 
(2013–20), this paper has tried to outline the main 
rehabilitative measures in use across Europe today and to set 
out the main issues in their design, implementation and 
evaluation, to assist policymakers and practitioners in the 
future. 
Alternatives or additions to punishment are established in the 
laws of many countries in Europe, with a particular focus on 
problem drug users. These measures, however, are available to 
varying degrees and although evaluations may suggest 
positive results, they are not conclusive. Such success 
depends partly on the degree to which they are accurately 
targeted to specific objectives and specific users. The policy 
arguments in favour of them seem to have developed along 
two lines — reducing harms to the individual and society by 
problem drug users, and addressing structural burdens on the 
assessments resulted in drug court orders, of which 53 % 
(Glasgow) and 38 % (Fife) were successfully completed. Costs 
were higher than drug treatment and testing orders, while 
reconviction rates were similar. Yet the sample size (470) was 
far smaller than that required to show a statistically significant 
difference, and the review concluded that the target group of 
offenders was extremely challenging, with many living chaotic 
lives, and the success of the drug court order should be 
judged accordingly. There was overwhelming support for the 
courts among the stakeholders. Despite this, the Scottish 
Government announced that the Fife court was ‘not viable’ 
and funding would stop in March 2014, with the Sheriff 
Principal preferring drug treatment and testing orders for 
efficiency (Robertson, 2013).
In 2010, a final process evaluation of the six pilot dedicated 
drug court sites in England and Wales found that staff and 
offenders viewed the courts as a useful initiative aimed at 
reducing re-offending and drug use (Kerr et al., 2011). The 
evaluation was mainly qualitative; while it considered the data 
of 1 501 offenders over two years, there were concerns that the 
data quality limited the robustness of the quantitative findings. 
The continuity of the judiciary between sentencing and review 
was seen as a key element, as was the existence of a dedicated 
coordinator. Nevertheless, the ability of the dedicated drug 
court to reduce recidivism was heavily dependent on treatment 
quality and other issues in offenders’ lives.
In Belgium, a quantitative analysis of 280 cases evaluated the 
drug court in Ghent positively (De Keulenaer and Thomaes, 
2010, cited in the 2011 Reitox national report). Of the 280 
cases, 148 (53 %) started treatment. At the time of the project 
evaluation, 91 persons had finished treatment (of which 41 
cases were closed successfully) and 57 persons were still in 
treatment. Commitment to the treatment programme resulted 
in less severe sentences at court. A qualitative evaluation 
showed that those involved were generally positive about the 
project, though there was still room for improvement (De 
Ruyver et al., 2010, cited in the 2011 Reitox national report). 
Most drug courts are in the United States, and four notable 
evaluations of them were published in 2011–12 with different 
headline assessments as to ‘success’ or ‘failure’, but sharing 
some similar conclusions. A systematic review of 154 studies 
(146 from the United States) published by the Campbell 
Collaboration concluded that adult, but not juvenile, drug 
courts have a substantial effect on recidivism (mean 12 % fall) 
(Mitchell et al., 2012). In contrast, a Drug Policy Alliance paper 
(2011) found that drug courts were an expensive way of 
dealing with low-level offenders, but they excluded those who 
would be more likely to benefit from the process. The 
importance of considering the nature of the offenders 
targeted also comes through in other studies; the five-year 
Multi-site adult drug court evaluation, funded by the US 
Department of Justice which gives grant assistance to drug 
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country, one may also consider the comprehensiveness of the 
different types of measures in addressing the different profiles 
of offenders found in that country — and this may again be the 
product of some of the factors listed. Taken together, the 
coherence of individual measures, and the 
comprehensiveness of coverage by different measures, may 
be indicative of the strength of a country’s general policy 
orientation towards rehabilitative responses to drug-using 
offenders. 
One problem identified in this paper is that large numbers of 
drug users are being diverted from the criminal justice system 
without any systematic follow-up or review of the 
effectiveness of the measures. In addition, where evaluations 
have occurred in European countries, such as with the drug 
courts, they have produced ambivalent results. Some 
problems may stem from a lack of clarity regarding the 
primary objective for many measures (whether it is to reduce 
incarceration while maintaining punishment, to address 
addiction, to reduce drug-related crime, or to reduce pressure 
on the justice system by non-problem users). Consequently 
there is a risk of loss of credibility for such rehabilitative 
measures, which may result in loss of political support and 
funding. There remains a need for monitoring and evaluation 
to better assess the effectiveness of such approaches as well 
as a need for improved documentation and recording 
practices in order to find out how often the measure was used. 
If many schemes are neither monitored nor evaluated, 
opportunities to learn lessons and make future improvements 
are being lost.
While it is widely agreed that the general deterrent of 
punishment has little effect on consumption levels of illicit 
drugs, drug use, together with its associated problems, 
continues to be considered by many as a criminal justice issue 
with a concern about moving too far away from punitive 
justice system by non-problem users — and it is important to 
keep the distinction between these in mind to avoid confusion. 
Unfortunately, it is not always clear that this distinction, or 
prioritisation, has been made in the design and 
implementation of the different measures. 
A number of challenges were encountered in conducting this 
work. Most fundamentally, the search question asked at the 
time of the different EMCDDA and other transnational data 
collections usually referred to treatment-oriented alternatives 
to prison, as that was the expression commonly used, and so 
some mechanisms may not have been included. Secondly, it is 
a constantly changing area, with countries introducing new 
and amended provisions on a regular basis. Thirdly, most of 
these provisions have not been the subject of formal 
evaluations and certainly not randomised controlled trials, so 
assessments of effectiveness are difficult. Finally, the 
opportunities for diversion into alternatives to punishment 
differ between judicial systems, and so programmes are 
unlikely to be directly transferable. However, it is still possible 
to identify broad conclusions and ideas that may be helpful to 
those considering introducing these approaches.
When considering the design of these measures, examination 
of the different options around Europe reveals a range of 
factors that may be useful to analyse the individual measures 
and to indicate the strength of policy priority in a country as a 
whole. Taken individually, each factor (see Table 1) broadly 
affects the number, and sometimes the type, of offender who 
may enter a programme. Yet the factors are also inter-
dependent; certain combinations of factors will affect the 
number who may complete a programme successfully, for 
example when the offender is matched with the most 
appropriate type of measure. Therefore, for each measure, 
combinations of factors should be checked for coherence. 
Finally, in designing a package of measures for any particular 
TABLE 1
Design factors for rehabilitative responses to offenders
Factor Range or options to consider
Legal system Limited to judges within the criminal law system; or outside it, such as in the civil or administrative systems
Direction to judiciary Optional or obligatory for the judiciary 
Geographical availability Availability ranging from few locations to nationwide
Stage of legal procedure Ranging from prior to arrest to time of sentencing
Offender diagnosis Availability ranging from a limited group of offenders (e.g. addicts, occasional cannabis users) to a very broad group 
of ‘drug users’
Offence Applicability ranging from only for drug use/personal possession offences to any offence linked with drug use or 
minor trafficking
Exclusion criteria Design may provide for multiple exclusions (e.g. possession of more than a small quantity, prior criminal record, 
recidivists) or may exclude only those accused of very serious offences
Response available Ranges from addiction treatment alone, to choices of treatment, education, aftercare and rehabilitation
Treatment setting Ranges from a secure facility to any appropriate setting, including outpatient facilities
Number of places available Ranges from very few to unlimited
Cost May be borne by the offender or by the state
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It is in this vein that the model implemented in Portugal, where 
the whole administration addressing drug users is under the 
healthcare sphere, with several rehabilitative measures 
available, has been described as a consistent and coherent 
policy (EMCDDA, 2011b). This approach has been functioning 
since 2001. There has been no major increase in drug 
problems that can be attributed to the new system (Hughes 
and Stevens, 2010), and there is no political will to return to 
the previous system. In 2013, the former Executive Director of 
UNODC, Antonio Maria Costa, said when interviewed about 
the Portuguese system, ‘I applaud the fact that finally we 
recognise that drug addicts are not criminals … I see drug 
policy, on the use side, as a health problem, period’ (Costa, 
2013). In addition, as described earlier, a number of other 
countries appear to be moving towards the gradual 
implementation of similar systems, recognising that first 
contact with the non-problem user is an opportunity for 
(indicated) prevention in order to address future levels of 
problem drug use. 
In summary, few countries in Europe have chosen to adopt 
widespread rehabilitative approaches, with most opting for 
simpler policies of decriminalisation or depenalisation — 
alternatives to prison, but not alternatives to punishment. The 
policies that are adopted are often carried out without robust 
monitoring or evaluation, despite the fact that investment in 
these could show dividends in the long run by providing 
information that can be used to improve the efficiency and 
effectiveness of the programme. But even if the resulting 
evidence is not strong, the key to success seems to be having 
a range of interventions available that can be matched 
appropriately to the needs of individuals with different types 
and levels of drug problems.
sentencing. This is visible, for example, in the prolonged 
discussions prior to implementing the law in Cyprus, the 
relatively high cost charged to offenders participating in the 
drugs awareness course in France, and the move in Italy to 
only offer a rehabilitation programme after the sanction has 
been completed. It is often assumed that greater deviation 
from general deterrent approaches will ‘send the wrong 
message’: that drug use is acceptable. To protect against this, 
rehabilitative measures may be accompanied by strict 
eligibility and procedural conditions (such as the Polish law 
that required drug addicts to have no previous convictions) 
and a cut-off level where only those diagnosed as sufficiently 
‘sick’ are treated, while those who are not sick should be 
punished. The frustration at official caution towards moving 
away from punishment was expressed succinctly by Judge Jo 
Ann Ferdinand, Presiding Judge of the Brooklyn Treatment 
Court, New York, who stated ‘This drug court is only allowed to 
continue because we constantly collect and submit statistics 
on recidivism rates, drug use rates, and cost-benefit 
calculations. Yet when I was just locking offenders up, nobody 
asked me for any of those’ (personal communication, June 
2015).
Some difficulties in implementing the measures appear to 
stem from the attempt at compromise between the two aims 
of treatment and punishment, which can pervade the entire 
policy cycle, from design, through implementation, to 
evaluation. As stated by the QCT Europe project, ‘success 
would thus depend in being able to [confront] the essential 
contradictions that the care–control dichotomy presents’. One 
solution to this dichotomy may be to slide the focus firmly 
across to treatment and education, minimising punishment 
— an option suggested in the wording to the UN conventions 
since 1971, and recently reiterated by the INCB (United 
Nations, 2008) and UNODC (2009). 
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